Association of Interleukin-6 and Myeloperoxidase with Insulin Resistance in Impaired Fasting Glucose Subjects

被引:7
|
作者
Agarwal A. [1 ]
Hegde A. [1 ]
Yadav C. [1 ]
Ahmad A. [1 ]
Manjrekar P.A. [1 ]
Srikantiah R.M. [1 ]
机构
[1] Department of Biochemistry, Center for Basic Sciences, Kasturba Medical College (Manipal University), Mangalore, 575004, Karnataka
关键词
Impaired fasting glucose; Insulin resistance; Interleukin-6; Myeloperoxidase;
D O I
10.1007/s12291-016-0567-8
中图分类号
学科分类号
摘要
Impaired fasting glucose (IFG) is a high risk subclinical condition for the progression of type 2 diabetes mellitus and the hyperglycemia seen in this condition is because of the development of insulin resistance (IR). Obesity, inflammation, oxidative stress and many other factors have been implicated in development of IR in type 2 diabetes mellitus and its successive complications. Current study was aimed to ascertain the correlation of inflammation and oxidative stress markers [interleukin-6 (IL-6) and myeloperoxidase (MPO)] with IR in subjects with IFG. In this study, 80 subjects (40 IFG, 40 healthy controls) aged 25–45 years were selected based on their fasting plasma glucose (FPG) values and clinical history. Serum insulin, IL-6 and MPO were estimated by ELISA method and IR was calculated using Homeostatic Model Assessment Index 2 (HOMA 2) calculator. Pearson’s correlation coefficient and independent sample ‘t’ test were used for statistical analysis. IL-6 and MPO were found to be significantly elevated in IFG group and both correlates significantly with IR (r 0.413, r 0.645). Only MPO had significant correlation with FPG (r 0.388). In conclusion, the association of altered levels of IL-6 and MPO with IR are suggestive of a role of inflammation and oxidative stress in the initiation and progression of IR in individuals with IFG. © 2016, Association of Clinical Biochemists of India.
引用
收藏
页码:33 / 38
页数:5
相关论文
共 50 条
  • [21] Association of insulin resistance with serum interleukin-6 level during normal pregnancy
    Jahromi, A. Sotoodeh
    FEBS JOURNAL, 2014, 281 : 100 - 100
  • [22] Decreased insulin secretion and dyslipidemia coexist in subjects with impaired fasting glucose
    Ozaki, K
    Okubo, M
    Mori, H
    Mito, K
    Hara, H
    Kohno, N
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 55 (02) : 159 - 164
  • [23] Association of periodontitis with insulin resistance, β-cell function, and impaired fasting glucose before onset of diabetes
    Islam, S. K. M. Azizul
    Seo, Minchul
    Lee, Young-Sil
    Moon, Seong-Su
    ENDOCRINE JOURNAL, 2015, 62 (11) : 981 - 989
  • [25] Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose
    Abdul-Ghani, MA
    Tripathy, D
    DeFronzo, RA
    DIABETES CARE, 2006, 29 (05) : 1130 - 1139
  • [26] The significance of impaired fasting glucose versus impaired glucose tolerance - Importance of insulin secretion and resistance
    Schianca, GPC
    Rossi, A
    Sainaghi, PP
    Maduli, E
    Bartoli, E
    DIABETES CARE, 2003, 26 (05) : 1333 - 1337
  • [27] Insulin resistance & secretion in subjects with normal fasting plasma glucose
    Hsieh, Chang-Hsun
    Hung, Yi-Jen
    Wu, Chung-Ze
    Lee, Shang-Sen
    Lee, Chien-Hsing
    Chen, g-Yu Chen
    Li, Jur-Chuan
    Kuo, Shi-Wen
    Kuo, Ko-Lin
    Pei, Dee
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2006, 124 (05) : 527 - 534
  • [28] Inflammatory adipocytokine interleukin-6 causes cardiac insulin resistance by decreasing glucose uptake
    Kim, HJ
    Park, SY
    Higashimori, T
    Kim, JK
    CIRCULATION, 2003, 108 (17) : 204 - 204
  • [29] Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose
    Hong, J.
    Gui, M. -H.
    Gu, W. -Q.
    Zhang, Y. -F.
    Xu, M.
    Chi, Z. -N.
    Zhang, Y.
    Li, X. -Y.
    Wang, W. -Q.
    Ning, G.
    DIABETIC MEDICINE, 2008, 25 (01) : 73 - 79
  • [30] Effects of n-3 pufas on fasting plasma glucose and insulin resistance in patients with impaired fasting glucose or impaired glucose tolerance
    Derosa, Giuseppe
    Cicero, Arrigo F. G.
    D'Angelo, Angela
    Borghi, Claudio
    Maffioli, Pamela
    BIOFACTORS, 2016, 42 (03) : 316 - 322